Skip to main content
Clinical Trials/IRCT20141209020258N168
IRCT20141209020258N168
Recruiting
Phase 3

Comparison of the effect of adding midazolam, paracetamol, tramadol and magnesium sulphate to ?ropivacaine in reducing pain and hemodynamic changes in intravenous local anesthesia

Arak University of Medical Sciences0 sites160 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
160
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Candidate of forearm surgery
  • ASA class 1 and 2
  • No Raynaud's disease
  • Absence of any vascular disease
  • No sickle cell anemia
  • No history of allergy to the drugs used in the study
  • Lack of cyanosis of the affected limb
  • Do not use drugs and psychotropic substances
  • No contraindication to intravenous anesthesia
  • No more than one fracture in the body or surgery

Exclusion Criteria

  • For any reason, local intravenous anesthesia may be terminated during surgery
  • Not consent to participate in study
  • Duration of operation less than 30 minutes or more than 90 minutes

Outcomes

Primary Outcomes

Not specified

Similar Trials